Safety and Efficacy of Drug Combinations Against Triple Infections
Status:
Completed
Trial end date:
2007-12-01
Target enrollment:
Participant gender:
Summary
This randomised, controlled, double blinded clinical study investigates the safety and
efficacy of the combination of albendazole, ivermectin and praziquantel in the treatment of
children aged 5-18 years co-infected with lymphatic filariasis, schistosomiasis and
soil-transmitted helminthiasis.
Phase:
N/A
Details
Lead Sponsor:
DBL -Institute for Health Research and Development